Quick summary: Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines .
Public recall detail
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines .
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Brand
Affected products
Issue
June 29, 2021
What you should do
- shortness of breath
- chest pain
- leg swelling
- persistent abdominal (belly) pain
- neurological symptoms, such as severe and persistent worsening headaches or blurred vision
- skin bruising or tiny blood spots under the skin beyond the site of the injection.
Additional official information
Background{}
Companies
Audiences
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.